Premium
Prognostic value of the immunohistochemical detection of p16 INK4 expression in nonsmall cell lung carcinoma
Author(s) -
Taga Satoshi,
Osaki Toshihiro,
Ohgami Akira,
Imoto Hideyuki,
Yoshimatsu Takashi,
Yoshino Ichiro,
Yano Koichi,
Nakanishi Ryoichi,
Ichiyoshi Yuji,
Yasumoto Kosei
Publication year - 1997
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/(sici)1097-0142(19970801)80:3<389::aid-cncr6>3.0.co;2-n
Subject(s) - immunohistochemistry , medicine , adenocarcinoma , carcinoma , pathology , lung cancer , cancer , oncology
BACKGROUND The product of the p16 INK4 /CDKN2/MTS1 (p16) controls the transition from the G1 phase to the S‐phase in the cell cycle by inhibiting the phosphorylation of the retinoblastoma gene product. A lack of p16 expression has been reported in various cancer cell lines and tumors; however, there have been only a few reports on the prognostic significance of p16 alteration. The authors studied p16 expression in nonsmall cell lung carcinoma (NSCLC) and also examined its correlation with clinicopathologic features and prognosis. METHODS p16 expression was determined by immunohistochemical analysis of 115 paraffin specimens of primary NSCLC that were curatively resected. The immunohistochemical study was performed using the labeled streptavidin‐biotin method with anti‐p16 rabbit polyclonal antibody. RESULTS Thirty‐one of 115 NSCLC specimens (27%) showed negative p16 staining. The frequency of negative p16 expression was significantly higher in squamous cell carcinoma (39.5%) than in adenocarcinoma (20.3%) ( P = 0.026). There were no statistically significant differences in the p16 status with respect to age, gender, smoking history, histologic differentiation, or stage of the disease. The Kaplan‐Meier survival curves demonstrated that patients with negative p16 expression survived for a significantly shorter period of time than those with positive p16 expression ( P = 0.043). p16 status was a significant prognostic factor, especially in patients with early stage disease (Stages I‐II) ( P = 0.039). CONCLUSIONS A lack of p16 INK4 expression in NSCLC was observed more frequently in squamous cell carcinoma than in adenocarcinoma, and also was found to be closely related to prognosis, especially in patients with early stage squamous cell carcinoma. Cancer 1997; 80:389‐95. © 1997 American Cancer Society.